Vaccines against Plasmodium vivax: a research challenge.

Manuel A. Patarroyo; Dayana Calderón; Darwin A. Moreno-Pérez

doi:10.1586/erv.12.91

Vaccines against Plasmodium vivax: a research challenge.

Manuel A. Patarroyo, Dayana Calderón, Darwin A. Moreno-Pérez

School of Medicine and Health Sciences

Research output: Contribution to journal › Review article › peer-review

28 Scopus citations

Abstract

Malaria caused by Plasmodium vivax continues being a public health problem in tropical and subtropical areas throughout the whole world. In spite of this species' epidemiological importance, its biological complexity has hampered advances being made in the field of vaccine development. Few antigens have been described and analyzed to date in preclinical and clinical studies, thereby highlighting the great challenge facing groups currently working on this parasite species. This review summarizes the most representative work done during the last few years and discusses the approaches adopted in making progress towards an anti-Plasmodium vivax vaccine.

Original language	English (US)
Pages (from-to)	1249-1260
Number of pages	12
Journal	Expert Review of Vaccines
Volume	11
Issue number	10
DOIs	https://doi.org/10.1586/erv.12.91
State	Published - Oct 2012

All Science Journal Classification (ASJC) codes

Immunology
Molecular Medicine
Pharmacology
Drug Discovery

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1586/erv.12.91

Cite this

@article{fc553ba411a646568c82d9b9a40fcae6,

title = "Vaccines against Plasmodium vivax: a research challenge.",

abstract = "Malaria caused by Plasmodium vivax continues being a public health problem in tropical and subtropical areas throughout the whole world. In spite of this species' epidemiological importance, its biological complexity has hampered advances being made in the field of vaccine development. Few antigens have been described and analyzed to date in preclinical and clinical studies, thereby highlighting the great challenge facing groups currently working on this parasite species. This review summarizes the most representative work done during the last few years and discusses the approaches adopted in making progress towards an anti-Plasmodium vivax vaccine.",

author = "Patarroyo, {Manuel A.} and Dayana Calder{\'o}n and Moreno-P{\'e}rez, {Darwin A.}",

note = "Copyright: This record is sourced from MEDLINE{\textregistered}/PubMed{\textregistered}, a database of the U.S. National Library of Medicine",

year = "2012",

month = oct,

doi = "10.1586/erv.12.91",

language = "English (US)",

volume = "11",

pages = "1249--1260",

journal = "Expert Review of Vaccines",

issn = "1476-0584",

publisher = "Expert Reviews Ltd.",

number = "10",

}

TY - JOUR

T1 - Vaccines against Plasmodium vivax

T2 - a research challenge.

AU - Patarroyo, Manuel A.

AU - Calderón, Dayana

AU - Moreno-Pérez, Darwin A.

N1 - Copyright: This record is sourced from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

PY - 2012/10

Y1 - 2012/10

N2 - Malaria caused by Plasmodium vivax continues being a public health problem in tropical and subtropical areas throughout the whole world. In spite of this species' epidemiological importance, its biological complexity has hampered advances being made in the field of vaccine development. Few antigens have been described and analyzed to date in preclinical and clinical studies, thereby highlighting the great challenge facing groups currently working on this parasite species. This review summarizes the most representative work done during the last few years and discusses the approaches adopted in making progress towards an anti-Plasmodium vivax vaccine.

AB - Malaria caused by Plasmodium vivax continues being a public health problem in tropical and subtropical areas throughout the whole world. In spite of this species' epidemiological importance, its biological complexity has hampered advances being made in the field of vaccine development. Few antigens have been described and analyzed to date in preclinical and clinical studies, thereby highlighting the great challenge facing groups currently working on this parasite species. This review summarizes the most representative work done during the last few years and discusses the approaches adopted in making progress towards an anti-Plasmodium vivax vaccine.

UR - http://www.scopus.com/inward/record.url?scp=84876453191&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876453191&partnerID=8YFLogxK

U2 - 10.1586/erv.12.91

DO - 10.1586/erv.12.91

M3 - Review article

C2 - 23176656

AN - SCOPUS:84876453191

SN - 1476-0584

VL - 11

SP - 1249

EP - 1260

JO - Expert Review of Vaccines

JF - Expert Review of Vaccines

IS - 10

ER -

Vaccines against Plasmodium vivax: a research challenge.

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this